Literature DB >> 24359246

Paroxysmal nocturnal hemoglobinuria is not a cause of anemia in patients with myelofibrosis.

Aziz Nazha1, Jeffrey L Jorgensen, Srdan Verstovsek.   

Abstract

Entities:  

Mesh：

Year:  2014        PMID： 24359246      PMCID： PMC4820818          DOI： 10.3109/10428194.2013.876628

Source DB:  PubMed          Journal:  Leuk Lymphoma        ISSN： 1026-8022


× No keyword cloud information.
  10 in total

Review 1.  Management of paroxysmal nocturnal hemoglobinuria in the era of complement inhibitory therapy.

Authors:  Charles J Parker
Journal:  Hematology Am Soc Hematol Educ Program       Date:  2011

Review 2.  Diagnosis and management of paroxysmal nocturnal hemoglobinuria.

Authors:  Charles Parker; Mitsuhiro Omine; Stephen Richards; Jun-Ichi Nishimura; Monica Bessler; Russell Ware; Peter Hillmen; Lucio Luzzatto; Neal Young; Taroh Kinoshita; Wendell Rosse; Gerard Socié
Journal:  Blood       Date:  2005-07-28       Impact factor: 22.113

3.  Polyclonal hematopoiesis maintained in patients with bone marrow failure harboring a minor population of paroxysmal nocturnal hemoglobinuria-type cells.

Authors:  Ken Ishiyama; Tatsuya Chuhjo; Hongbo Wang; Akihiro Yachie; Mitsuhiro Omine; Shinji Nakao
Journal:  Blood       Date:  2003-04-03       Impact factor: 22.113

4.  Minor population of CD55-CD59- blood cells predicts response to immunosuppressive therapy and prognosis in patients with aplastic anemia.

Authors:  Chiharu Sugimori; Tatsuya Chuhjo; Xingmin Feng; Hirohito Yamazaki; Akiyoshi Takami; Masanao Teramura; Hideaki Mizoguchi; Mitsuhiro Omine; Shinji Nakao
Journal:  Blood       Date:  2005-09-22       Impact factor: 22.113

5.  Relationship between the membrane inhibitor of reactive lysis and the erythrocyte phenotypes of paroxysmal nocturnal hemoglobinuria.

Authors:  M H Holguin; L A Wilcox; N J Bernshaw; W F Rosse; C J Parker
Journal:  J Clin Invest       Date:  1989-11       Impact factor: 14.808

6.  Acute lymphoblastic leukemic transformation in a patient with chronic idiopathic myelofibrosis and paroxysmal nocturnal hemoglobinuria: a case report and review of the literature.

Authors:  Saad Paul Shaheen; Sameer S Talwalkar; Ruth Simons; Lung Yam
Journal:  Arch Pathol Lab Med       Date:  2005-01       Impact factor: 5.534

7.  Origin and fate of blood cells deficient in glycosylphosphatidylinositol-anchored protein among patients with bone marrow failure.

Authors:  Chiharu Sugimori; Kanako Mochizuki; Zhirong Qi; Naomi Sugimori; Ken Ishiyama; Yukio Kondo; Hirohito Yamazaki; Akiyoshi Takami; Hirokazu Okumura; Shinji Nakao
Journal:  Br J Haematol       Date:  2009-07-28       Impact factor: 6.998

8.  Paroxysmal nocturnal hemoglobinuria with myelofibrosis: progression to acute myeloblastic leukemia.

Authors:  J Nakahata; M Takahashi; I Fuse; Y Nakamori; N Nomoto; H Saitoh; W Tatewaki; A Imanari; T Takeshige; T Koike
Journal:  Leuk Lymphoma       Date:  1993-12

9.  Deficiency of the GPI anchor caused by a somatic mutation of the PIG-A gene in paroxysmal nocturnal hemoglobinuria.

Authors:  J Takeda; T Miyata; K Kawagoe; Y Iida; Y Endo; T Fujita; M Takahashi; T Kitani; T Kinoshita
Journal:  Cell       Date:  1993-05-21       Impact factor: 41.582

10.  Detection of paroxysmal nocturnal hemoglobinuria clones in patients with myelodysplastic syndromes and related bone marrow diseases, with emphasis on diagnostic pitfalls and caveats.

Authors:  Sa A Wang; Olga Pozdnyakova; Jeffrey L Jorgensen; L Jeffrey Medeiros; Dariusz Stachurski; Mary Anderson; Azra Raza; Bruce A Woda
Journal:  Haematologica       Date:  2008-11-10       Impact factor: 9.941
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.